⚠️ For educational and research purposes only. This tool does not provide medical diagnosis. Consult a board-certified dermatologist or clinical geneticist for interpretation.

πŸ”¬ Vitiligo SNP Risk Analyzer

Upload your raw genetic data to assess vitiligo-associated risk alleles across 5 biological pathways

1
Upload
2
Parse
3
Analyze
4
Report
πŸ“

Drop your genetic data file here

Supports 23andMe raw data (.txt) and VCF files (.vcf)

23andMe .txt VCF 4.x TSV raw genotype
OR paste raw data below
πŸ”’ Privacy: All analysis runs entirely in your browser. Your genetic data is never uploaded to any server.
πŸ“‹ Analyzed SNPs:
rs3761548rs2232365 rs3761547rs5902434 rs11798415rs10876864 rs2476601rs706779 rs4908760rs3757247 rs2111485rs12150220 rs2236313rs3823355 rs7758128rs1393350 rs59374417

πŸ—ΊοΈ Pathway Breakdown

πŸ“Š Detailed Analysis

SNP ID Gene Your Genotype Risk Allele Status OR Pathway

Hom. Risk = homozygous for risk allele Β· Het = heterozygous (one copy) Β· Ref = protective/reference genotype Β· N/A = not found in file

βš–οΈ Regulatory Note: These recommendations are based on guidelines from the American Academy of Dermatology (AAD), the British Association of Dermatologists (BAD/NICE), and European Medicines Agency (EMA) approved therapies. Ruxolitinib (Opzelura) is FDA-approved for non-segmental vitiligo (June 2022). Risk SNPs do not predict treatment response β€” only a physician can guide therapy.